[EN] ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME [FR] MODULATEURS DES RECEPTEURS D'ANDROGENES ET METHODES DE TRAITEMENT DE MALADIES UTILISANT CEUX-CI
[EN] PYRABACTIN ANALOGUES TO MODULATE PLANT DEVELOPMENT<br/>[FR] ANALOGUES DE LA PYRABACTINE POUR MODULER LE DÉVELOPPEMENT VÉGÉTAL
申请人:UNIV GENT
公开号:WO2015113944A1
公开(公告)日:2015-08-06
The present invention relates to compounds which can be used to control plant development. Indeed, the present invention discloses a new class of pyrabactin analogues which have a physiological effect on -for example- seed germination, and/or stomatal closure, and/or have developmental effects on root and shoot development and organogenesis. Hence, the latter compounds can be used to control plant development such as -for example- increasing the tolerance of plants to drought stress or to control physiological phenomena such as pre-harvest sprouting, tolerance to pathogens etc.
Androgen receptor modulators and methods of treating disease using the same
申请人:Schlienger Nathalie
公开号:US20070004679A1
公开(公告)日:2007-01-04
Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
Androgen receptor modulators and method of treating disease using the same
申请人:Schlienger Nathalie
公开号:US20060014739A1
公开(公告)日:2006-01-19
Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME
申请人:Schlienger Nathalie
公开号:US20080009489A1
公开(公告)日:2008-01-10
Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
Photocatalyst-free visible-light-promoted C(sp<sup>2</sup>)–P coupling: efficient synthesis of aryl phosphonates
作者:Shiqi Xiang、Min Li、Zhen Xia、Chen Fang、Wen Yang、Wei Deng、Ze Tan
DOI:10.1039/d3ob01987j
日期:——
A novel and efficientmethod for the synthesis of aryl phosphonates fromarylhalides and trialkylphosphites via EDA complex-based photochemistry has been developed. It is demonstrated that aryl radicals, generated from the photoexcitation of the EDA complex formed by arylhalide and potassium thioacetate, could be intercepted with trialkylphosphite to produce the corresponding aryl phosphonates in